Sesen Bio Inc (SESN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SESN | BMY | AMGN | GILD | GSK |
| Company | Sesen Bio Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 11.4640 | 48.21 | 264.63 | 66.25 | 39.37 |
| High | 12.5760 | 48.67 | 267.64 | 66.72 | 39.75 |
| Low | 11.4000 | 48.12 | 260.68 | 66.16 | 39.37 |
| Last | 12.5760 | 48.64 | 267.32 | 66.42 | 39.69 |
| Change | +0.8540 | +0.34 | +4.57 | +0.26 | +0.42 |
| % Change | +7.29% | +0.70% | +1.74% | +0.39% | +1.07% |
| Volume | 93,330 | 3,459,450 | 1,033,575 | 3,164,645 | 838,622 |
| 20-Day Average Volume | 1,386,090 | 10,952,628 | 2,127,873 | 6,073,670 | 2,890,287 |
| Previous Close | 11.7220 | 48.30 | 262.75 | 66.16 | 39.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5886 | 50.84 | 272.46 | 69.87 | 41.22 |
| 20-Day Raw Stochastic | 86.57% | 13.99% | 21.95% | 4.89% | 9.55% |
| 20-Day Relative Strength | 55.97% | 39.14% | 41.63% | 28.67% | 35.42% |
| Weighted Alpha | +28.83 | -29.61 | +6.50 | -25.06 | +8.99 |
| Today's Opinion | 32% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 24% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | Hold | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.41% since 02/28/23 | +0.61% since 04/12/24 | -0.18% since 04/12/24 | -2.61% since 04/12/24 | -2.69% since 04/12/24 |
| Low | 0.5300 on 03/06/23 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 39.15 on 04/18/24 |
| High | 0.6449 on 03/02/23 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 41.06 on 04/15/24 |
| 1-Month | |||||
| %Chg | +4.80% since 02/07/23 | -6.23% since 03/19/24 | -1.81% since 03/19/24 | -9.70% since 03/19/24 | -6.51% since 03/19/24 |
| Low | 0.5250 on 02/13/23 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 39.15 on 04/18/24 |
| High | 0.6449 on 03/02/23 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 43.45 on 03/25/24 |
| 3-Month | |||||
| %Chg | +18.08% since 12/07/22 | -3.06% since 01/19/24 | -13.32% since 01/19/24 | -24.06% since 01/19/24 | -0.29% since 01/19/24 |
| Low | 0.4500 on 12/19/22 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 38.56 on 01/25/24 |
| High | 0.6500 on 01/18/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 43.84 on 03/07/24 |
| 6-Month | |||||
| %Chg | +2.11% since 09/07/22 | -14.00% since 10/19/23 | -4.92% since 10/19/23 | -15.49% since 10/19/23 | +11.80% since 10/19/23 |
| Low | 0.3650 on 09/27/22 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 33.67 on 11/02/23 |
| High | 0.6850 on 09/15/22 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 43.84 on 03/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 127,956 | 97,892,464 | 140,812,720 | 82,374,304 | 81,384,712 |
| Shares Outstanding, K | 203,492 | 2,026,759 | 535,919 | 1,245,077 | 2,072,440 |
| Annual Sales | 40,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 37,725,000,000 |
| Annual Net Income | -19,880,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 6,129,940,000 |
| Last Quarter Sales | 40,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 9,980,060,000 |
| Last Quarter Net Income | 20,460,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 433,200,000 |
| 60-Month Beta | 0.83 | 0.39 | 0.58 | 0.19 | 0.64 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 02/28/23 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.72 on 01/31/24 |
| Latest Earnings Date | 02/27/23 | 04/25/24 | 05/02/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | 0.397 on 02/22/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | 02/22/24 |
| Ratios | |||||
| Price/Earnings ttm | 11.72 | 6.38 | 14.16 | 9.96 | 10.29 |